CHERESE LAPORTA: Open Payments
NPI 1437206943 · PATCHOGUE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,055 in 44 payments from 16 companies in 2025. Trend: 2023 $1,520 · 2024 $1,288 · 2025 $1,055
Food & beverage: $1,055
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $164 |
| ABBVIE INC. | 6 | $156 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $100 |
| Amgen Inc. | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 3 | $85 |
| Exact Sciences Corporation | 3 | $77 |
| Braeburn Inc. | 3 | $73 |
| Orexo US, Inc. | 3 | $60 |
| Lilly USA, LLC | 2 | $54 |
| Indivior Inc. | 2 | $50 |
Products named: QULIPTA, BRIXADI, JARDIANCE, Zubsolv, UBRELVY, MOUNJARO, SUBLOCADE, REPATHA.
Industry payments across NY — which companies pay providers there.
